Complement in Antibody-Mediated Rejection of the Kidney Graft: From Pathophysiology to Clinical Practice
- PMID: 40283639
- PMCID: PMC12027593
- DOI: 10.3390/jcm14082810
Complement in Antibody-Mediated Rejection of the Kidney Graft: From Pathophysiology to Clinical Practice
Abstract
Antibody-mediated rejection (AMR) is a leading cause of kidney graft failure. Complement activation is involved in the AMR process. Our aim is to provide the current understanding of the pathophysiology related to complement-mediated injury in AMR, to present the current evidence regarding complement blockade in AMR management, and to point out emerging therapies and future directions in this area. The complement system plays an important role in the onset and progression of AMR. There is a balance between complement-dependent and -independent mechanisms in the development of rejection lesions. Classic and leptin pathways are involved in this process. C4d positivity is no longer a mandatory feature for AMR diagnosis but remains an independent predictor of negative outcomes. The current evidence regarding AMR treatment is limited. Terminal and proximal complement blockade has gained recognition in clinical practice. Eculizumab and C1 inhibitors are effective in the treatment of AMR as adjuvant therapies to the standard of care. The availability of novel complement inhibitors will lead to more effective and tailored treatment strategies.
Keywords: antibody; complement; kidney; pathophysiology; rejection; transplant; treatment.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures

References
-
- Haas M., Mirocha J., Reinsmoen N.L., Vo A.A., Choi J., Kahwaji J.M., Peng A., Villicana R., Jordan S.C. Differences in Pathologic Features and Graft Outcomes in Antibody-Mediated Rejection of Renal Allografts Due to Persistent/Recurrent versus de Novo Donor-Specific Antibodies. Kidney Int. 2017;91:729–737. doi: 10.1016/j.kint.2016.10.040. - DOI - PubMed
-
- Sellarés J., De Freitas D.G., Mengel M., Reeve J., Einecke G., Sis B., Hidalgo L.G., Famulski K., Matas A., Halloran P.F. Understanding the Causes of Kidney Transplant Failure: The Dominant Role of Antibody-Mediated Rejection and Nonadherence. Am. J. Transplant. 2012;12:388–399. doi: 10.1111/j.1600-6143.2011.03840.x. - DOI - PubMed
-
- Arias-Cabrales C., Redondo-Pachón D., Pérez-Sáez M.J., Gimeno J., Sánchez-Güerri I., Bermejo S., Sierra A., Burballa C., Mir M., Crespo M., et al. Renal Graft Survival According to Banff 2013 Classification in Indication Biopsies. Nefrologia. 2016;36:660–666. doi: 10.1016/j.nefro.2016.05.018. - DOI - PubMed
-
- Aubert O., Loupy A., Hidalgo L., Duong van Huyen J.-P., Higgins S., Viglietti D., Jouven X., Glotz D., Legendre C., Lefaucheur C., et al. Antibody-Mediated Rejection Due to Preexisting versus De Novo Donor-Specific Antibodies in Kidney Allograft Recipients. J. Am. Soc. Nephrol. 2017;28:1912–1923. doi: 10.1681/ASN.2016070797. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources